NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,165 | -21.1% | 2,024 | -21.9% | 0.01% | -20.0% |
| Q2 2023 | $261,458 | +2.0% | 2,591 | -7.0% | 0.02% | +7.1% |
| Q1 2023 | $256,404 | -8.4% | 2,787 | -9.7% | 0.01% | -12.5% |
| Q4 2022 | $279,871 | -8.5% | 3,085 | -23.4% | 0.02% | -23.8% |
| Q3 2022 | $306,000 | -27.0% | 4,026 | -18.8% | 0.02% | -30.0% |
| Q2 2022 | $419,000 | -59.4% | 4,957 | -57.8% | 0.03% | -60.5% |
| Q1 2022 | $1,032,000 | -14.7% | 11,757 | -15.0% | 0.08% | -8.4% |
| Q4 2021 | $1,210,000 | -10.8% | 13,838 | -16.6% | 0.08% | -25.2% |
| Q3 2021 | $1,357,000 | -11.4% | 16,593 | -1.8% | 0.11% | -10.5% |
| Q2 2021 | $1,532,000 | +5.1% | 16,889 | -1.0% | 0.12% | -11.4% |
| Q1 2021 | $1,458,000 | -24.2% | 17,061 | -16.3% | 0.14% | -25.5% |
| Q4 2020 | $1,924,000 | – | 20,380 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |